HOME
About
Technical
Media
Careers
Contact us
语言

2023-09-01

欧米尼医药两个自主研发吸入装置获得权威专家共识推荐

2023-07-28

OMNI's new inhalation preparation industrialization project (warehouse 1) main structure has been completed

2023-07-13

OMNI's Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation was accepted by CDE

2023-06-13

Two doctors of our company won the Yangtze Delta Drug Advanced Research Institute outstanding postgraduate tutors

2023-05-08

OMNI LIMS system was officially launched to help the digital transformation of the laboratory

2023-04-17

OMNI Pharma and its subsidiary SMC donated 1000 medical ultrasonic nebulizers to help improve the medical level in remote areas

2023-03-24

The National Kick-off Meeting of the OMN-TB-301 study was successfully held in Guangzhou

2023-02-14

Omni Pharma was selected in the list of "Potential Unicorn" enterprises in Jiangsu in 2022 and the list of "unicorn" cultivating enterprises in Suzhou in 2022
上一页
下一页

备案号：沪ICP备12031398号-1